Toleranzia - Home
  • Our vision

    "To improve quality of life for autoimmune patients"

  • About Toleranzia

    Toleranzia is developing the
    Re-TolerogenTM platform technology, with the potential to revolutionize the treatment of autoimmune disease. The Re-TolerogenTM technology involves a targeted disease-specific treatment that re-sets the immune system by inducing immune tolerance thereby preventing or ameliorating disease, thus offering long term benefits for autoimmune patients.